tirzepatide diabetic retinopathy The popular #diabetes and weight loss medication #tirzepatide (brand name Mounjaro or Zepbound) may lower the risk of #retinopathy, a leading cause of vision loss, according to Dr. Szilárd Kiss and Study: Tirzepatide Lowers Risk of

However, it also turns out that interaction of GLP-1 agonists with receptors found on brain cells leads to feelings of satiety and reduced hunger

With antiamyloid antibodies Leqembi (lecanemab) and Kisunla (donanemab) now FDAapproved for early Alzheimers, attention is turning to combination strategies that address multiple disease pathways

Published in eClinicalMedicine, the narrative review brings together evidence from dozens of studies to assess how these medications are being used, where they show promise and what concerns remain

Discover whether you're a candidate for PlexusDx compounded semaglutide therapy and how personalized dosing works